EGFR and breast cancer: For example, the ERBB signaling pathway, which was perturbed by AS in C3 compared to C5 (Fig. 3D), promotes breast cancer tumorigenesis by activating the PI3K/Akt pathway46, which was indeed upregulated in C3 (Fig. 3E).